Crowdonomics
All companies
Health Care Originals logo

Health Care Originals

Raising nowOperating

Health Care Originals, Inc.

Healthcare · Rochester, NY · Founded 2016

Immigrant-foundedWoman-foundedMinority-founded
Visit website24 followers on WeFunder · as of Oct 4, 2026

AI-powered respiratory care for asthma & copd patients

Raising nowRaising now on WeFunder

This company has an open fundraising round.

$0 raised356 days left
View the live round
Post-money valuation ⓘ
$14.6M
As of Nov 2024 · from Reg CF Offering (2024) · pre-money + amount raised, not a traded price
Total raised
$10,763,415
Crowd $1.6M · Private $9.2M · 3 rounds since 2024
Latest share price
$1.52
Reg CF · Preferred Stock · Nov 2024 offering price

Financials

FY2022–FY2025 · from SEC filings · hover any figure for its source
$8K
−$3.3M
2022
2023
$5K
−$2.7M
2024
$14K
−$2.3M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 reviewed
FY2023 reviewed
FY2024 unaudited
FY2025 unaudited
Income statement
Revenue
$7,687
—
$5,051
$13,878
Cost of goods sold
$13,712
—
$5,439
$0
Gross margin
-78%
—
-8%
100%
Net income
-$3,323,424
—
-$2,650,362
-$2,315,617
Taxes paid
$0
—
$0
$0
Balance sheet
Cash
$7,256
—
$576,962
$544,546
Accounts receivable
$0
—
$3,746
$0
Total assets
$402,586
—
$1,014,947
$914,511
Short-term debt
$174,318
—
$179,166
$481,998
Long-term debt
$6,591,383
—
$1,307,945
$1,532,945
Total liabilities
$6,765,701
—
$1,487,111
$2,014,943
Other
Headcount
—
7
—
10

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$13.0M
pre-money
Reg CF · Preferred · Nov 2024

Blue bars are the pre-money valuation the company stated for a priced round.

Cap table

Principal holders% as the filing states it, Jan 29, 2026

  • Safar Partners30.8%of company
  • Jared Dwarika21.5%of company
  • Sharon Samjitsingh20.8%of company

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $0 / $290K
Raised $1.6M / $1.2MInvestors 20Post-money $14.6M
Raised $9.2MInvestors 23

Team

8 people
Sharon SamjitsinghFounder
CEO & Co-Founder

Healthtech disruptor. Drove 20X revenue growth & led $150M portfolio at $7B conglomerate. Top 100 Women in Wearables. Entrepreneur in Residence at NYSERDA. 7 healthcare patents. Engineering BSc & U. of Rochester Entrepreneurship & Management MS.

Jared Dwarika
COO & Co-Founder

Device sales & manufacturing maven. 20 years industry experience. 14 healthcare patents allowed & 12 more pending. Grew sales by 30x to $5M at Western Scientific. Featured speaker at MEDICA - world’s #1 medical device event. Henley Business School MBA.

Cameron Jacox
Chief Growth Officer

Growth maestro. Former Chief Growth Officer at Lark Health. Scaled AI chronic disease platform to $1B+. Former executive at exited startups MyFinance, NarrativeDx, & Vincere Health. Babson College Business Management BS.

Jennifer Chambers
Chief Medical Officer, MD MBA FACP

Clinical expert. Ex-Medical Director at Capital Blue Cross. Board-certified in Internal Medicine and Hospice & Palliative Medicine. Academic Development Committee Chair of the Penn State Harrisburg Board of Advisors. Penn State MD & MBA.

Kristin Nuckols
Chief Clinical Officer, Imago Rehab

Pioneer of at-home neuro rehab. Harvard Wyss Institute Research Therapist. NBCOT Innovation Award, 2024. Co-Founder, Imago Rehab. Boston University Doctor of Occupational Therapy & James Madison University Master of Occupational Therapy

Doug Roy
SVP, Business Development

Sales powerhouse. Grew revenues by over 10X and secured contracts with all major health insurers at MedScope (acquired by Medical Guardian). University of Wisconsin-Milwaukee Marketing BBA.

Keith Wilson
Managing Partner, Cranberry Capital
Parinaz Motamedy
Board Member

Names and titles as disclosed on SEC Form C, WeFunder. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

23 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form COct 5, 20260002037345-26-000005
    EDGAR
  • Form C-ARJan 29, 20260002037345-26-000003
    EDGAR
  • Form C/ASep 16, 20250002037345-25-000003
    EDGAR
  • Form C/AApr 17, 20250001670254-25-000373
    EDGAR
  • Form C/AMar 3, 20250001670254-25-000134
    EDGAR
  • Form CNov 1, 20240001670254-24-001046
    EDGAR
  • Form DOct 30, 20240002037345-24-000002
    EDGAR
Source: ManualCIK 0002037345Share price $1.52

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.